GRCK Logo.png
Grey Cloak Tech Inc. Releases Independent Report
October 20, 2020 08:30 ET | Grey Cloak Tech Inc.
LAS VEGAS, Oct. 20, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Grey Cloak Tech Inc. (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary...
fior-markets-logo.jpg
Global Surgical Sealants and Adhesives Market Is Expected to Reach USD 4.34 billion by 2027 : Fior Markets
September 17, 2020 04:00 ET | Fior Markets
Newark, NJ, Sept. 17, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global surgical sealants and adhesives market is expected to grow from USD 2.08 billion in 2019 and to...
fior-markets-logo.jpg
Global Drug Discovery Outsourcing Market Is Expected to Reach USD 6.75 Billion by 2027 : Fior Markets
September 10, 2020 03:42 ET | Fior Markets
Newark, NJ, Sept. 10, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global drug discovery outsourcing market is expected to grow from USD 3.82 billion in 2019 and to...
Clear Link Between Heart Disease and COVID-19 Found by Intermountain Researchers -- Long-Term Implications Unknown
August 18, 2020 15:44 ET | Intermountain Healthcare
Salt Lake City, Utah, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Severe damage to the lungs is one of COVID-19’s most harrowing effects, making breathing hard or impossible for those who’re severely...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
August 13, 2020 07:00 ET | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020
August 07, 2020 08:00 ET | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
Madrigal logo.jpg
Madrigal Pharmaceuticals Reports 2020 Second Quarter Financial Results and Highlights
August 06, 2020 06:50 ET | Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) today announced its second quarter 2020 financial results and highlights: “The Madrigal team and...
QMI-Logo-Long-1000px.jpg
Cardiovascular And Soft Tissue Repair Patch Market To Reach USD 7,610.5 Billion By 2028
July 20, 2020 05:05 ET | Quince Market Insights
Pune, India, July 20, 2020 (GLOBE NEWSWIRE) -- The global Cardiovascular and Soft Tissue Repair Patch Market is forecast to reach USD 7,610.5 billion by 2028, growing at a CAGR of 9.3% over the...
SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators
July 07, 2020 08:30 ET | ARCA biopharma, Inc.
Integrin A5 may be a new target for intervening in the cell infectious processFindings may lead to the development of precision therapeutic approaches to prevent SARS-CoV-2-cell entry while preserving...
Marius_logo_CMYK.jpg
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
May 21, 2020 06:30 ET | Shah Capital
RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead...